Showing results (121-130 of 334) with videos related to
Sort By:
Pageof 34
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1990
A case of rabies in North AmericaM Bhatt, E Wolters, J Tsui, et al.British Journal of Cancer|August 1, 1991
Assessment of quality of life in small-cell lung cancer using a Daily Diary Card developed by the Medical Research Council Lung Cancer Working PartyP M Fayers, N M Bleehen, D J Girling, et al.Clinical Pharmacology and Therapeutics|April 1, 1984
Disposition of oral lisuride in Parkinson's diseaseR S Burns, G Gopinathan, M Hümpel, et al.The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|November 1, 1979
Sodium valproate in the treatment of cerebellar disordersA N Neophytides, P F Teychenne, R F Pfeiffer, et al.Annals of Neurology|October 1, 1991
Pleuropulmonary disease associated with dopamine agonist therapyM H Bhatt, S P Keenan, J A Fleetham, et al.British Journal of Clinical Pharmacology|January 1, 1980
Cross tolerance between two dopaminergic ergot derivatives--bromocriptine and lergotrileP F Teychenne, A J Rosin, C N Plotkin, et al.Annals of Neurology|October 1, 1989
Nigrostriatal function in humans studied with positron emission tomographyW R Martin, M R Palmer, C S Patlak, et al.Gastroenterology|March 1, 1979
Hepatocellular injury with distinctive mitochondrial changes induced by lergotrile mesylate: a dopaminergic ergot derivativeP F Teychenne, E A Jones, K G Ishak, et al.Neurology|April 1, 1985
Dystonia and calcification of the basal gangliaT A Larsen, H G Dunn, J E Jan, et al.Neurology|June 1, 1989
A double-blind, placebo-controlled, dose-ranging study to investigate the safety and efficacy of CY 208-243 in patients with Parkinson's diseaseJ K Tsui, E C Wolters, R F Peppard, et al.Pageof 34